|
"tsai ch"的相關文件
顯示項目 446-455 / 596 (共60頁)
<< < 40 41 42 43 44 45 46 47 48 49 > >>
每頁顯示[10|25|50]項目
| 中國醫藥大學 |
2002 |
Molecular analysis of syndromic congenital heart disease using short tandem repeat markers and semiquantitative polymerase chain reaction method
|
Shi, YR; Hsieh, KS; Wu, JY; Lee, CC; Tsai, CH; Tsai, FJ |
| 中國醫藥大學 |
2002 |
Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma
|
Tsai, MH; Lin, CD; Hsieh, YY; Chang, FCC; Tsai, FJ; Chen, WC; Tsai, CH |
| 中山醫學大學 |
2001 |
The correlation between alteration of p16 gene and clinical status in oral squamous cell carcinoma.
|
Tsai, CH; Yang, CC; Chou, LS; Chou, MY |
| 中山醫學大學 |
2001 |
The correlation between alteration of p16 gene and clinical status in oral squamous cell carcinoma.
|
Tsai, CH; Yang, CC; Chou, LS; Chou, MY |
| 中國醫藥大學 |
2001 |
Androgen receptor trinucleotide polymorphism in endometriosis
|
Hsieh, YY; Chang, CC; Tsai, FJ; Wu, JY; Tsai, CH; Tsai, HD |
| 中國醫藥大學 |
2001 |
Further evidence that fibroblast growth factor receptor 2 mutations cause Antley-Bixler syndrome
|
Tsai, FJ; Wu, JY; Yang, CF; Tsai, CH |
| 中國醫藥大學 |
2001 |
Relation of polymorphism in the promotor region for the human osteocalcin gene to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan
|
Chen, HY; Tsai, HD; Chen, WC; Wu, JY; Tsai, FJ; Tsai, CH |
| 中國醫藥大學 |
2001 |
Polymorphisms for interleukin-1 beta (IL-1 beta)-511 promoter, IL-1 beta exon 5, and IL-1 receptor antagonist: Nonassociation with endometriosis
|
Hsieh, YY; Chang, CC; Tsai, FJ; Wu, JY; Shi, YR; Tsai, HD; Tsai, CH |
| 中國醫藥大學 |
2001 |
p21 gene codon 31 arginine/serine polymorphism: Non-association with endometriosis
|
Hsieh, YY; Tsai, FJ; Chang, CC; Chen, WC; Tsai, CH; Tsai, HD; Lin, CC |
| 中國醫藥大學 |
2001 |
Mutation analysis of Crouzon syndrome and identification of one novel mutation in Taiwanese patients
|
Tsai, FJ; Yang, CF; Wu, JY; Tsai, CH; Lee, CC |
顯示項目 446-455 / 596 (共60頁)
<< < 40 41 42 43 44 45 46 47 48 49 > >>
每頁顯示[10|25|50]項目
|
